Efficient preparation of an N-aryl β-amino acid via asymmetric hydrogenation and direct asymmetric reductive amination en route to Ezetimibe

  • Guuske F. Busscher
  • , Laurent Lefort
  • , Jozef G.O. Cremers
  • , Marco Mottinelli
  • , Roel W. Wiertz
  • , Ben de Lange
  • , Yutaka Okamura
  • , Yukinori Yusa
  • , Kazuhiko Matsumura
  • , Hideo Shimizu
  • , Johannes G. de Vries
  • , André H.M. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)
601 Downloads (Pure)

Abstract

Two routes for the preparation of an N-aryl β-amino acid, an important precursor for the cholesterol-lowering drug Ezetimibe, were investigated. The first pathway proceeds via an Rh- or Ir-catalyzed asymmetric hydrogenation of N-aryl enamine giving the desired product with up to 82% ee. The other pathway involves a direct asymmetric reductive amination (DARA) of the β-keto ester which yielded the β-amino ester in high yield and 97% ee. Subsequent copper-catalyzed N-arylation gave the target compound.
Original languageEnglish
Pages (from-to)1709-1714
Number of pages6
JournalTetrahedron Asymmetry
Volume21
Issue number13
DOIs
Publication statusPublished - 2010

Fingerprint

Dive into the research topics of 'Efficient preparation of an N-aryl β-amino acid via asymmetric hydrogenation and direct asymmetric reductive amination en route to Ezetimibe'. Together they form a unique fingerprint.

Cite this